Filed in archive
FDA Approvals
, Neurological Disorders
, Treatment
by Gloria Gamat on May 9, 2008
Requip (ropinirole hydrochloride) tablets - product of GlaxoSmithKline (GSK) - are for the treatment of moderate to severe Restless Legs Syndrome (RLS).
© Brymo
From the NINDS-NIH:
Now the FDA has approved the generic versions of Requip - Ropinirole Hydrochloride. The said generics approved are from the following generic drug makers:
Read more from the FDA News.
© Brymo
From the NINDS-NIH:
Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and an uncontrollable urge to move when at rest in an effort to relieve these feelings. RLS sensations are often described by people as burning, creeping, tugging, or like insects crawling inside the legs. Often called paresthesias (abnormal sensations) or dysesthesias (unpleasant abnormal sensations), the sensations range in severity from uncomfortable to irritating to painful.
Now the FDA has approved the generic versions of Requip - Ropinirole Hydrochloride. The said generics approved are from the following generic drug makers:
- Roxane Laboratories Inc.
- Teva Pharmaceuticals USA
- Par Pharmaceuticals Inc.
- Mylan Pharmaceuticals Inc.
Read more from the FDA News.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/122932
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for First Generic Ropinirole, Approved by The FDA:
|
Rating: 6.67 out of 3 vote(s) cast.
|
Response from:
Trusted.MD Network
Requip (ropinirole hydrochloride) tablets - product of GlaxoSmithKline (GSK) - are for the treatment of moderate to severe Restless Legs Syndrome (RLS).
© Brymo
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
